This observation is supported by other findings that ALDH2 expression was decreased in patients with the lethal outcome of PCa over patients that survived for at least eight years without metastases after an adjustment for the Gleason score [107]. The gene discussed is ALDH2; the disease is posterior cortical atrophy.